Related Experiment Video

Updated: Jun 13, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

Relationship between regional atrophy rates and cognitive decline in mild cognitive impairment

Carrie R McDonald1, Lusineh Gharapetian, Linda K McEvoy

  • 1Department of Psychiatry, University of California, San Diego, La Jolla, CA, USA. camcdonald@ucsd.edu

Neurobiology of Aging
|May 18, 2010
PubMed

Insights

Brain atrophy in specific regions is linked to distinct cognitive declines in individuals with mild cognitive impairment (MCI). These findings highlight regional atrophy rates as key indicators of cognitive impairment progression.

Area of Science:

  • Neuroimaging
  • Cognitive Neuroscience
  • Neurology

Background:

  • Mild cognitive impairment (MCI) is a transitional stage between normal aging and dementia.
  • Understanding the neural correlates of cognitive decline in MCI is crucial for early diagnosis and intervention.

Purpose of the Study:

  • To investigate the relationship between regional brain atrophy rates and domain-specific cognitive decline over two years in individuals with MCI.
  • To determine if regional atrophy contributes to cognitive decline independently of overall disease progression.

Main Methods:

  • Longitudinal magnetic resonance imaging (MRI) scans from 103 MCI patients and 90 healthy controls were analyzed.
  • High-throughput image analysis quantified percent cortical volume loss (atrophy rates) between baseline and 24-month scans.
  • Stepwise regression analyses examined the association between regional atrophy rates and decline in language, memory, and executive functions, controlling for covariates.

Main Results:

  • In MCI patients, left temporal lobe atrophy correlated with naming decline.
  • Bilateral temporal, left frontal, and left anterior cingulate atrophy were associated with semantic fluency decline.
  • Left entorhinal atrophy predicted memory decline, while bilateral frontal atrophy was linked to executive function decline.

Conclusions:

  • Regional atrophy rates in MCI are associated with specific patterns of cognitive decline, affecting language, memory, and executive functions.
  • These associations appear partially independent of overall disease progression, suggesting distinct pathological mechanisms.
  • MRI-derived regional atrophy measures offer valuable insights into the neural underpinnings of cognitive impairment in MCI.

More Related Videos

Using Retinal Imaging to Study Dementia09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

Generalized Psychophysiological Interaction (PPI) Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease09:38

Generalized Psychophysiological Interaction (PPI) Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

Related Concept Videos

Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...